Bacha Jeffrey - Insider Stock Trading - OpenInsider

CIK: 1432149 - Address: Suite 720-999 West Broadway, Vancouver, A1 V5Z 1K5

18 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	15	1	-0	3	4	27	313	58
P	%wins				67	27	50	57	46	62	51

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
10/10/17 08:10	10/6/17	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO	P	9	0.8725	0	10	19	64	D
6/28/17 11:29	6/26/17	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO	P	24	3.60	0	7	14	53	D
6/6/17 17:12	6/6/17	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO	P	11	2.12	0	5	12	47	D
5/8/17 16:58	5/5/17	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO	P	6	2.20	0	3	6	42	D	183	67	-46	-56	-44	-16	-18	-12	2	5
2/2/17 11:44	2/1/17	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO	P	20	5.00	0	4	11	39	D	634	513	-31	11	34	57	38	24	2	-7	-11	-50
11/30/15 13:59	11/25/15	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,Dir	P	11	1.47	0	8	6	138	D	52	67	119	198	88	24	17	7	-5	-12	-37	-44	316	163
10/9/15 11:38	10/8/15	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	P,CEO	P	2	0.7986	0	3	2	130	D	-21	-8	23	47	102	5	16	12	-2	-6	42	15	53	564
9/22/15 10:00	9/18/15	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	P,CEO	P	3	0.8300	0	4	3	127	D	-21	-20	-1	14	49	58	32	-5	-5	-9	5	35	8	749
7/28/15 20:59	7/25/15	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	P,CEO	P.d	6	0.6000	0	10	9	123	D	-44	-24	-11	-18	-10	-11	5	10	0	-7	-8	40	42	999
7/16/15 07:05	7/16/15	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	P,CEO	P.d	30	0.6000	0	50	79	113	D	-42	-38	-29	-28	-28	-23	-11	-2	3	-1	-10	45	64	999
1/22/15 12:32	1/22/15	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO,P	P	5	0.6567	0	8	13	63	D		-16	-18	-13	-17	-11	-16	-11	1	-3	3	20	-20	28
12/10/14 15:47	12/9/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,P	P	2	0.9000	0	3	5	56	D		6	4	18	7	1	-1	0	-3	-12	-6	-3	-22	39
11/26/14 19:33	11/26/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,P	P	2	0.9200	0	3	5	53	D		-18	2	29	8	-3	0	6	0	-6	-12	-13	-21	64
9/19/14 13:39	9/18/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DO	CEO,P	P	4	0.9800	0	4	9	51	D		-7	-26	4	46	18	28	17	6	-3	-12	-9	-9	-12
9/16/14 08:43	9/15/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,P	P	4	0.7500	0	5	12	47	D		-20	-41	-8	3	11	5	5	15	23	5	6	10	-4
3/20/14 16:38	3/18/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,P	P	13	1.30	0	10	31	42	D		-16	33	54	52	-1	-7	-4	-5	-8	3	-28	-18	-28
2/21/14 19:10	2/21/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,P	P	5	1.00	0	5	19	32	D			-14	-10	3	13	1	6	11	38	21	11	-28	-28
2/13/14 17:05	2/13/14	DMPI	Delmar Pharmaceuticals, Inc.	NV	Health	Drug	Pharmaceutical Preparations	Bacha Jeffrey	A1	DOT	CEO,P	P	4	0.8000	0	5	23	27	D			-21	-18	-4	3	-5	-4	1	7	56	27	-23	-23

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact